The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL29 August 12 Special Report
- NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015
- New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits
- More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says
- Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)
- NCI Deputy Barker Hits FDA, Calls for New Incentives for Pharmaceutical Industry; Barker Co-Founded Dietary Supplements Firm
- Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says
- NCI Director Defends Goal to Eliminate Suffering, Death From Cancer by 2015
- Feinstein Reintroduces New National Cancer Act
- NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.
- Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.
- Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says
- AACR thanks NCI for funds, provides platform for von Eschenbach’s 2015 goal. Also 2015 goal not a dream, but a vision, NCI director says.
- 2015 Goal Not a Dream, But a Vision, Director Says
- National Dialogue plans biospecimen network
- NCI names Porter Novelli executive as director for strategic dissemination.
- A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.
CCL
Vol.
26
No.
8
August 29, 2003
- Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting
- New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer
- Center Seeks HER-2 Positive Breast Cancer Patients
- Melanoma Cancer Vaccine Tested By Cooperative Group
- NCI Study Tests Donor T Cells Against Breast Cancer
- Insufficient Data To Prove Digital Mammograms Better, Michigan Consortium Finds
- New Publication Describes End-of-Life Care Projects
- Clinical Trials Approved By NCI Last Month Are Listed
TCL
Vol.
29
No.
35
September 26, 2003
- NCAB forms subcommittee to develop NCI biomedical technologies initiative.
- Also R01 payline likely to fall below 20th percentile in FY04.
- NCI renews Roswell Park’s core grant for five years.
- Survey supports removal of cancer care cuts from Medicare bills.
- NIH wins A-76 competition for extramural support services.
- Ohio State to study center expansion.
- Includes Sept. Business & Regulatory Report.
CCL
Vol.
26
No.
9
September 26, 2003
- Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer
- Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds
- NCCN Updates Myeloma Clinical Practice Guidelines
- Wilmot Researchers Study Combination for Lymphoma
- Colorado Researchers Study Massage To Reduce Symptoms
- Longer Infusion More Effective For Pancreatic Cancer
- Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo
- Almost Half of Faculty on IRBs Have Industry Ties, Study Finds
- Non-Invasive Test May Detect Lung Cancer In Early Stages
- Fish Oil May Help Prevent Weight Loss In Cancer Patients
- IARC Finds Betel Quid, Areca Nut Chewing Causes Cancer
- Clinical Trials Approved By NCI
TCL
Vol.
29
No.
36
October 03, 2003
TCL
Vol.
29
No.
37
October 10, 2003
- FDA cancer therapeutics review split among three units in reorganization.
- Also Cancer policy board urges NCI to convene panel on long-term care for childhood cancer survivors.
- NCI funds four radiation oncology cancer disparities research partnerships.
- NIH funds eight centers for health disparities research.
- NHGRI’s ENCODE project to identify all genome parts.
- Norris Cotton Cancer Center wins core grant renewal.
